Literature DB >> 15148234

Treatment of Erdheim-Chester disease with cladribine: a rational approach.

C Myra, L Sloper, P J Tighe, R S McIntosh, S E Stevens, R H S Gregson, M Sokal, A P Haynes, R J Powell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15148234      PMCID： PMC1772168          DOI： 10.1136/bjo.2003.035584

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  14 in total

1.  Interferon therapy for orbital infiltration secondary to Erdheim-Chester disease.

Authors:  B Esmaeli; A Ahmadi; R Tang; J Schiffman; R Kurzrock
Journal:  Am J Ophthalmol       Date:  2001-12       Impact factor: 5.258

2.  Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.

Authors:  S Seto; C J Carrera; M Kubota; D B Wasson; D A Carson
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

3.  Erdheim-Chester disease. Case report and review of the literature.

Authors:  R L Miller; L R Sheeler; T W Bauer; R M Bukowski
Journal:  Am J Med       Date:  1986-06       Impact factor: 4.965

4.  Erdheim-Chester disease presenting as malignant exophthalmos.

Authors:  I Rozenberg; J Wechsler; F Koenig; B Brun; D Larde; Y Raulo; J Hazard; Y Pinaudeau; G Coscas
Journal:  Br J Radiol       Date:  1986-02       Impact factor: 3.039

5.  Orbital manifestations of Erdheim-Chester disease.

Authors:  M G Alper; L E Zimmerman; F G Piana
Journal:  Trans Am Ophthalmol Soc       Date:  1983

6.  Cladribine activity in adult langerhans-cell histiocytosis.

Authors:  A Saven; C Burian
Journal:  Blood       Date:  1999-06-15       Impact factor: 22.113

7.  Erdheim-Chester disease: two cases of orbital involvement.

Authors:  T G Sheidow; D A Nicolle; J G Heathcote
Journal:  Eye (Lond)       Date:  2000-08       Impact factor: 3.775

8.  Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy.

Authors:  C J Carrera; C Terai; M Lotz; J G Curd; L D Piro; E Beutler; D A Carson
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

9.  Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine.

Authors:  G Juliusson; R Lenkei; J Liliemark
Journal:  Blood       Date:  1994-06-15       Impact factor: 22.113

10.  A phase I study of intermittent infusion cladribine in patients with solid tumors.

Authors:  K Kobayashi; N J Vogelzang; S M O'Brien; R L Schilsky; E E Vokes; M J Ratain
Journal:  Cancer       Date:  1994-07-01       Impact factor: 6.860
View more
  22 in total

1.  Erdheim-Chester disease: The role of video-assisted thoracoscopic surgery in diagnosing and treating cardiac involvement.

Authors:  Aoife Egan; Dan Sorajja; Dawn Jaroszewski; Farouk Mookadam
Journal:  Int J Surg Case Rep       Date:  2011-12-08

2.  FDG-PET in the Erdheim-Chester disease: its diagnostic and follow-up role.

Authors:  Emőke Steňová; Boris Steňo; Pavol Povinec; František Ondriaš; Jana Rampalová
Journal:  Rheumatol Int       Date:  2010-12-07       Impact factor: 2.631

Review 3.  Erdheim-Chester Disease: a comprehensive review of the literature.

Authors:  Roei D Mazor; Mirra Manevich-Mazor; Yehuda Shoenfeld
Journal:  Orphanet J Rare Dis       Date:  2013-09-08       Impact factor: 4.123

4.  Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.

Authors:  Eli L Diamond; Lorenzo Dagna; David M Hyman; Giulio Cavalli; Filip Janku; Juvianee Estrada-Veras; Marina Ferrarini; Omar Abdel-Wahab; Mark L Heaney; Paul J Scheel; Nancy K Feeley; Elisabetta Ferrero; Kenneth L McClain; Augusto Vaglio; Thomas Colby; Laurent Arnaud; Julien Haroche
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

5.  Treatment of skeletal Erdheim-Chester disease with zoledronic acid: case report and proposed mechanisms of action.

Authors:  Thitinan Srikulmontree; H Davis Massey; W Neal Roberts
Journal:  Rheumatol Int       Date:  2006-08-25       Impact factor: 2.631

6.  Anakinra as efficacious therapy for 2 cases of intracranial Erdheim-Chester disease.

Authors:  Eli L Diamond; Omar Abdel-Wahab; Benjamin H Durham; Ahmet Dogan; Neval Ozkaya; Lynn Brody; Maria Arcila; Christian Bowers; Mark Fluchel
Journal:  Blood       Date:  2016-08-17       Impact factor: 22.113

7.  Erdheim-chester disease.

Authors:  Myoung-Shin Kim; Chae-Hwa Kim; Seok-Joo Choi; Chong-Hyun Won; Sung-Eun Chang; Mi-Woo Lee; Jee-Ho Choi; Kee-Chan Moon
Journal:  Ann Dermatol       Date:  2010-11-05       Impact factor: 1.444

8.  [Erdheim-Chester disease of the orbit with compressive optic neuropathy].

Authors:  K Manousaridis; J Casper; M P Schittkowski; H Nizze; R F Guthoff
Journal:  Ophthalmologe       Date:  2010-03       Impact factor: 1.059

9.  Erdheim-Chester disease: a case report with pulmonary, kidney involvement and bone lesions.

Authors:  Aziza Mounach; Abderrzak Nouijai; Lahsen Achemlal; Abdellah El Maghraoui; Ahmed Bezza
Journal:  Rheumatol Int       Date:  2009-07-09       Impact factor: 2.631

Review 10.  Erdheim-Chester disease.

Authors:  Julien Haroche; Laurent Arnaud; Fleur Cohen-Aubart; Baptiste Hervier; Frédéric Charlotte; Jean-François Emile; Zahir Amoura
Journal:  Curr Rheumatol Rep       Date:  2014-04       Impact factor: 4.592
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.